CD274 and non-small cell lung carcinoma: In clinical NSCLC samples, PD-L1 expression was significantly increased in the cisplatin-resistant group, and PD-L1 expression was positively correlated with c-Jun expression but negatively correlated with HDAC3 expression (Fig. 8).